|
DHX16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.463000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.930200E-01 |
| Normal-vs-Stage2 |
9.715600E-01 |
| Normal-vs-Stage3 |
7.902800E-01 |
| Normal-vs-Stage4 |
4.821600E-02 |
| Stage1-vs-Stage2 |
7.837400E-01 |
| Stage1-vs-Stage3 |
9.729400E-01 |
| Stage1-vs-Stage4 |
1.654390E-01 |
| Stage2-vs-Stage3 |
8.262000E-01 |
| Stage2-vs-Stage4 |
2.361800E-01 |
| Stage3-vs-Stage4 |
2.575200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.907800E-01 |
| Normal-vs-AfricanAmerican |
9.759600E-01 |
| Normal-vs-Asian |
7.687000E-01 |
| Caucasian-vs-AfricanAmerican |
8.420200E-01 |
| Caucasian-vs-Asian |
7.860600E-01 |
| AfricanAmerican-vs-Asian |
8.287200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.436600E-01 |
| Normal-vs-Female |
8.974000E-01 |
| Male-vs-Female |
9.630000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.867000E-01 |
| Normal-vs-Extreme_Weight |
2.659400E-01 |
| Normal-vs-Obese |
5.172600E-01 |
| Normal-vs-Extreme_Obese |
4.149000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.883200E-01 |
| Normal_Weight-vs-Obese |
6.839400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.253200E-01 |
| Extreme_Weight-vs-Obese |
9.399900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.508400E-01 |
| Obese-vs-Extreme_Obese |
3.619800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.730990E-01 |
| Normal-vs-Age(41-60Yrs) |
4.777200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.729200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.017500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.876600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.696800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.383530E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.163000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.253890E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.698000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.774300E-02 |
| Normal-VS-Type2 PRCC |
1.067940E-02 |
| Normal-VS-KIRP CIMP |
7.734300E-02 |
| Normal-VS-Unclassified PRCC |
4.040000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.96670000022159E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.878100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.576310E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.644600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.894250E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.846400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.987200E-01 |
| Normal-vs-N1 |
9.880600E-01 |
| Normal-vs-N2 |
4.122500E-03 |
| N0-vs-N1 |
6.325800E-01 |
| N0-vs-N2 |
9.174000E-02 |
| N1-vs-N2 |
9.771800E-02 |
|
|
